C. Roumie, E. Mitchel, L. Kaltenbach, P. Arbogast, P. Gideon, and M. Griffin. Stroke; a journal of cerebral circulation, 39 (7):
2037-45(July 2008)4450<m:linebreak></m:linebreak>PUBM: Print-Electronic; JID: 0235266; 0 (Anti-Inflammatory Agents, Non-Steroidal); 0 (Cyclooxygenase 2 Inhibitors); 2008/04/24 aheadofprint; ppublish;<m:linebreak></m:linebreak>New-user designs.
S. Lagakos. The New England journal of medicine, 355 (2):
113-7(July 2006)4860<m:linebreak></m:linebreak>LR: 20071115; JID: 0255562; 0 (Cyclooxygenase 2 Inhibitors); 0 (Lactones); 0 (Sulfones); 0 (rofecoxib); CON: N Engl J Med. 2005 Mar 17;352(11):1092-102. PMID: 15713943; 2006/06/26 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència.
M. Maclure, B. Carleton, and S. Schneeweiss. Medical care, 45 (10 Supl 2):
S44-9(October 2007)6352<m:linebreak></m:linebreak>GR: AG19463/AG/NIA NIH HHS/United States; JID: 0230027; 0 (Cyclooxygenase 2 Inhibitors); ppublish;<m:linebreak></m:linebreak>CER.